Department of Orthopaedic Surgery, Duke University Medical Center, Durham, NC.
School of Medicine, Duke University Medical Center, Durham, NC.
J Arthroplasty. 2022 Jul;37(7S):S642-S646. doi: 10.1016/j.arth.2022.01.015. Epub 2022 Feb 18.
Cutibacterium spp. is an emerging pathogen in total hip arthroplasty (THA) that is not well evaluated in the literature. This study reported on the presentation and management of THA complicated by positive intraoperative Cutibacterium cultures.
This is a retrospective review of 27 revision THAs with positive monomicrobial intraoperative Cutibacterium cultures from 2014 to 2020 at one academic center. These patients were divided into two cohorts based on meeting Musculoskeletal Infection Society (MSIS) criteria for prosthetic joint infections (PJI). Patient demographics, preoperative labs, and hip aspirate results were collected. Procedure performed, postoperative antibiotic regimens, and repeat infections were recorded. Data were compared with univariate analysis.
Nine of the 27 patients preoperatively met MSIS criteria for PJI. Patients with positive MSIS criteria had significantly higher median synovial cell count (P = .048) and neutrophil percentage in a preoperative aspirate (P = .050). Eight patients with positive MSIS criteria received six weeks of postoperative antibiotics compared to two patients with negative criteria. Two patients with positive MSIS criteria had a postoperative infection that required further surgical intervention. Four patients with negative criteria who required further surgical intervention did not receive postoperative antibiotics after initial revision.
While often categorized as a contaminant, Cutibacterium is an increasingly recognized pathogen in THA. Cutibacterium can often present with normal serology, which may result in misdiagnosis as aseptic THA failure. Without the administration of postoperative antibiotics after positive cultures, there is a risk for persistent infection requiring further surgical intervention.
类棒状杆菌属(Cutibacterium spp.)是全髋关节置换术(THA)中的一种新兴病原体,其在文献中的评估效果不佳。本研究报告了由术中类棒状杆菌属阳性培养物引起的 THA 表现和处理方法。
这是对 2014 年至 2020 年在一个学术中心接受 27 例 THA 翻修术且术中类棒状杆菌属单培养阳性的患者的回顾性研究。这些患者根据符合肌肉骨骼感染学会(MSIS)假体关节感染(PJI)标准分为两组。收集了患者的人口统计学、术前实验室和髋关节抽吸结果。记录了所进行的手术、术后抗生素方案和重复感染。采用单变量分析比较数据。
27 例患者中有 9 例术前符合 MSIS 对 PJI 的标准。符合 MSIS 标准的患者的术前抽吸物中滑膜细胞计数中位数明显更高(P =.048),中性粒细胞百分比更高(P =.050)。8 例符合 MSIS 标准的患者接受了 6 周的术后抗生素治疗,而 2 例不符合标准的患者接受了 2 周的术后抗生素治疗。2 例符合 MSIS 标准的患者发生了术后感染,需要进一步手术干预。4 例不符合标准的患者需要进一步手术干预,但在初次翻修后未接受术后抗生素治疗。
虽然类棒状杆菌属通常被归类为污染物,但它是 THA 中越来越被认可的病原体。类棒状杆菌属感染常伴有正常的血清学,这可能导致误诊为无菌性 THA 失败。如果在阳性培养物后未给予术后抗生素治疗,存在持续感染并需要进一步手术干预的风险。